These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19946934)

  • 1. Quetiapine treatment and improved cognitive functioning in borderline personality disorder.
    Van den Eynde F; De Saedeleer S; Naudts K; Day J; Vogels C; van Heeringen C; Audenaert K
    Hum Psychopharmacol; 2009 Dec; 24(8):646-9. PubMed ID: 19946934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of quetiapine for impulsivity and affective symptoms in borderline personality disorder.
    Van den Eynde F; Senturk V; Naudts K; Vogels C; Bernagie K; Thas O; van Heeringen C; Audenaert K
    J Clin Psychopharmacol; 2008 Apr; 28(2):147-55. PubMed ID: 18344724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine in patients with borderline personality disorder: an open-label trial.
    Adityanjee ; Romine A; Brown E; Thuras P; Lee S; Schulz SC
    Ann Clin Psychiatry; 2008; 20(4):219-26. PubMed ID: 19034754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective deficit in executive functioning among patients with borderline personality disorder.
    Haaland VØ; Esperaas L; Landrø NI
    Psychol Med; 2009 Oct; 39(10):1733-43. PubMed ID: 19243646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of quetiapine on cognitive functions in schizophrenic patients: a preliminary single-trial ERP analysis.
    Zhang Y; Lehmann M; Shobeiry A; Höfer D; Johannes S; Emrich HM; Dietrich DE
    Pharmacopsychiatry; 2009 Jul; 42(4):129-34. PubMed ID: 19585390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
    Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS
    Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quetiapine for the treatment of borderline personality disorder; an open-label study.
    Perrella C; Carrus D; Costa E; Schifano F
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):158-63. PubMed ID: 17045720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuropsychological dysfunctions in personality borderline disorder: detection strategies].
    Arza R; Díaz-Marsa M; López-Micó C; de Pablo NF; López-Ibor JJ; Carrasco JL
    Actas Esp Psiquiatr; 2009; 37(4):185-90. PubMed ID: 19927229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive function in borderline personality disorder.
    Dinn WM; Harris CL; Aycicegi A; Greene PB; Kirkley SM; Reilly C
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):329-41. PubMed ID: 14751430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological dissociation and neuropsychological functioning in borderline personality disorder.
    Haaland VØ; Landrø NI
    Acta Psychiatr Scand; 2009 May; 119(5):383-92. PubMed ID: 19120046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neurocognitive model of borderline personality disorder: effects of childhood sexual abuse and relationship to adult social attachment disturbance.
    Minzenberg MJ; Poole JH; Vinogradov S
    Dev Psychopathol; 2008; 20(1):341-68. PubMed ID: 18211741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Planning in borderline personality disorder: evidence for distinct subpopulations.
    Bustamante ML; Villarroel J; Francesetti V; Ríos M; Arcos-Burgos M; Jerez S; Iturra P; Solari A; Silva H
    World J Biol Psychiatry; 2009; 10(4 Pt 2):512-7. PubMed ID: 19658046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Executive functions in borderline personality disorder.
    Hagenhoff M; Franzen N; Koppe G; Baer N; Scheibel N; Sammer G; Gallhofer B; Lis S
    Psychiatry Res; 2013 Nov; 210(1):224-31. PubMed ID: 23764434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeat neurobehavioral study of borderline personality disorder.
    van Reekum R; Links PS; Finlayson MA; Boyle M; Boiago I; Ostrander LA; Moustacalis E
    J Psychiatry Neurosci; 1996 Jan; 21(1):13-20. PubMed ID: 8580113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurocognitive subtypes of schizophrenia according to performance at verbal fluency tasks].
    Robert PH; Thauby S; Migneco V; Chaix I; Caci H; Benoit M; Pringuey D; Darcourt G
    Encephale; 1996; 22(6):435-42. PubMed ID: 10901836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficits in visual functions and neuropsychological inconsistency in Borderline Personality Disorder.
    Beblo T; Saavedra AS; Mensebach C; Lange W; Markowitsch HJ; Rau H; Woermann FG; Driessen M
    Psychiatry Res; 2006 Dec; 145(2-3):127-35. PubMed ID: 17070927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological functioning in patients with borderline personality disorder.
    Sprock J; Rader TJ; Kendall JP; Yoder CY
    J Clin Psychol; 2000 Dec; 56(12):1587-600. PubMed ID: 11132573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years.
    Berger GE; Proffitt TM; McConchie M; Kerr M; Markulev C; Yuen HP; O'Donnell C; Lubman D; Polari A; Wood S; Amminger PG; McGorry PD
    J Clin Psychiatry; 2008 Nov; 69(11):1702-14. PubMed ID: 19036233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.